The John Morris Group is excited to announce our new distribution agreement with Bruker Cellular Analysis. John Morris Group will be responsible for distributing and servicing the Optofluidic product range within Australia and New Zealand.
Bruker Cellular Analysis is empowering scientists to unlock the full potential of each cell and is driving the next era of functional cell biology to advance therapeutics development. Bruker Beacon Optofluidic Platform enables scientists to reveal the most complete insights on cell functions and obtain a full view of the behaviour of each cell.
The unique suite of proven high-throughput solutions offers unparalleled resolution and speed, accelerating the insights that are key to advancing discoveries that can profoundly improve the prevention and treatment of disease. The award-winning Beacon platforms are used by researchers across the globe, including those at the top global pharmaceutical companies as well as leading academic research institutes and universities.
To learn more about the Bruker Cellular Analysis products and how the team at John Morris Group can assist you, please contact us.
